Product Image

CoQ10 + Alpha Lipoic Acid + Acetyl L-Carnitine HCl

Nature's Lab
4.8
★ ★ ★ ★ ★
(36 ratings)
Acetyl L-Carnitine 500 mg
Product Image
Score81
A well-built mitochondrial trio with substantial CoQ10, alpha-lipoic acid, and ALCAR. Strong dosing is offset by limited form and testing detail.
How scoring works
Quantity:60 Capsule(s) • (30 servings)
Goals:
Energy
Anti-Aging
Metabolism Boost
Cognitive Support
Productivity Boost
Brain Health
Mental Focus
Weight Loss

Score 81

A well-built mitochondrial trio with substantial CoQ10, alpha-lipoic acid, and ALCAR. Strong dosing is offset by limited form and testing detail.
How scoring works
$23.98($0.79 per serving)
Walmart
$ 23.98
Report prices

Analysis

ALCAR supports mitochondrial fuel transport, CoQ10 supports cellular energy transfer, and alpha-lipoic acid adds antioxidant and metabolic support. The three ingredients address complementary pathways rather than padding the formula.

Each active reaches a meaningful amount, with ALCAR at a practical starting level. CoQ10 form and alpha-lipoic-acid isomer are not specified, so absorption and form quality cannot be fully compared.

Two capsules provide strong formula depth for energy and healthy-aging routines. Weight-loss effects remain indirect and should not be treated as a primary reason to use the combination.

Who is it for
  • Adults seeking broad mitochondrial support
  • Users wanting CoQ10, ALA, and ALCAR together
Best for
  • Cellular-energy routines
  • Multi-pathway healthy-aging support

Pros

  • Meaningful CoQ10 amount
  • Meaningful alpha-lipoic acid
  • Useful ALCAR HCl serving

Cons

  • CoQ10 form is not specified
  • ALA isomer is not stated
  • No purity testing supplied

Warnings

  • Alpha-lipoic acid may lower blood glucose
  • CoQ10 may affect warfarin management
  • ALCAR may feel stimulating to sensitive users

Nutrient quality

91 Highest impact

Three complementary mitochondrial actives provide meaningful amounts and strong goal alignment. Incomplete form detail is the main quality limitation in an otherwise focused formula.

.

Ingredient transparency

81 Highest impact

All active amounts are disclosed without a hidden blend. Some chemical forms, daily-use directions, and non-active ingredients are not supplied.

.

Customer satisfaction

62 Moderate impact

The available rating is strong and the sample is small. Detailed feedback was not supplied, so repeated complaints and alignment with the intended use remain uncertain.

.

Value for money

85 Highest impact

Meaningful complementary doses provide good practical value. The formula avoids low-value extras that could inflate the cost.

.
Report analysis

Goals

Energy
Impact
Highest effect
A Goal FitA- Strength of SupportA- CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mgCoenzyme Q-10 · 200 mg

Acetyl L-carnitine, CoQ10, and alpha-lipoic acid directly support mitochondrial fuel handling and redox balance. The three main actives have relevant human evidence for cellular energy or fatigue support in appropriate users.

CoQ10 and alpha-lipoic acid are substantial, while the 500 mg acetyl L-carnitine amount reaches the lower effective range. Every active and amount is disclosed, including acetyl L-carnitine hydrochloride and CoQ10.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Anti-Aging
Impact
Highest effect
A- Goal FitA- Strength of SupportB+ CoverageA+ Formula Quality
Coenzyme Q-10 · 200 mg

Acetyl L-carnitine, alpha-lipoic acid, and CoQ10 form a strongly targeted combination for mitochondrial energy and oxidative defense. Each active has relevant human evidence, although the formula does not establish a direct effect on lifespan.

The serving supplies 500 mg of acetyl L-carnitine, 300 mg of alpha-lipoic acid, and 200 mg of CoQ10. Amounts are fully disclosed and meaningful, but the CoQ10 form and independent purity assurance are not provided.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Metabolism Boost
Impact
Highest effect
B+ Goal FitA- Strength of SupportB+ CoverageA+ Formula Quality
Coenzyme Q-10 · 200 mgAcetyl L-Carnitine · 500 mg

Acetyl L-carnitine, alpha-lipoic acid, and CoQ10 form a focused mitochondrial energy formula with strong metabolic relevance. The actives support fatty-acid transport, redox balance, glucose handling, and cellular energy production through complementary mechanisms.

Each ingredient reaches a meaningful amount and the label discloses every dose. The carnitine amount sits at the lower end of common targeted use, but the overall formula retains good depth without filler.

Study evidence
Acetyl L-Carnitine Adverse 1 study
Cognitive Support
Impact
High effect
B Goal FitB Strength of SupportB- CoverageA Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl-L-carnitine, alpha-lipoic acid, and CoQ10 create a focused mitochondrial-energy and antioxidant formula. The carnitine amount reaches a useful starting level, while the supporting antioxidants are substantial.

The active amounts are fully disclosed and the combination is mechanistically coherent. No direct memory herb, circulation enhancer, or stress adaptogen broadens the cognitive coverage.

Study evidence
Acetyl L-Carnitine Supportive 20 studies
Productivity Boost
Impact
High effect
B Goal FitB Strength of SupportC CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mgAcetyl L-Carnitine · 500 mg

Acetyl-L-carnitine, alpha-lipoic acid, and CoQ10 provide complementary support for cellular energy. The formula may help mental and physical fatigue through a clear mitochondrial strategy.

It lacks an acute alertness ingredient, neurotransmitter precursor, or stress-response adaptogen. The label also omits detailed purity and molecular-form information for the actives.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Acetyl L-Carnitine Supportive 1 study
Brain Health
Impact
High effect
B- Goal FitB- Strength of SupportB CoverageA Formula Quality

The combination is coherently aimed at mitochondrial energy and oxidative-stress support. Acetyl L-carnitine, alpha-lipoic acid, and CoQ10 are each present at meaningful disclosed amounts.

The formula does not directly cover memory, synaptic plasticity, or stress adaptation. It is a focused choice for cellular energy support rather than a comprehensive nootropic blend.

Study evidence
Acetyl L-Carnitine Supportive 19 studies

Ingredients

IngredientAmount per serving
N-Acetyl L-Carnitine HCl
500 mg
Alpha Lipoic Acid
300 mg
Co-Enzyme Q-10 (CoQ10)
200 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
Acetyl L-Carnitine · 500 mg OverallScore80
A- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The formula supplies ALCAR HCl at the bottom of the standard effective range. Its exact amount is clearly stated, while no manufacturing or purity assurance is provided. Cost efficiency is only modest even with meaningful alpha-lipoic acid and CoQ10 doses.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsEnergy forAcetyl L-Carnitine
  2. Carnitine for fatigue in multiple sclerosis.
    Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S · The Cochrane database of systematic reviews · 2012
    Systematic review1 studies pooledEnergy forAcetyl L-Carnitine
  3. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.
    Rossini M; Di Munno O; Valentini G; Bianchi G; Biasi G; Cacace E; Malesci D; La Montagna G; Viapiana O; Adami S · Clinical and experimental rheumatology · 2007
    Randomized trial102 participantsEnergy forAcetyl L-Carnitine
  4. Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort.
    Montanari S; Jansen R; Schranner D; Kastenmüller G; Arnold M; Janiri D; Sani G; Bhattacharyya S; Mahmoudian Dehkordi S; Dunlop BW; Rush AJ; Penninx BWHJ; Kaddurah-Daouk R; Milaneschi Y · Translational psychiatry · 2025
    Cohort study2,574 participantsEnergy forAcetyl L-Carnitine
  5. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
    Malaguarnera G; Catania VE; Bertino G; Chisari LM; Castorina M; Bonfiglio C; Cauli O; Malaguarnera M · Current pharmaceutical design · 2022
    Randomized trial92 participantsAnti-Aging forAcetyl L-Carnitine
  6. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  7. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  8. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  9. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  10. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  11. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  12. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  13. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
    Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Randomized trial60 participantsEnergy forAcetyl L-Carnitine
  14. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G · Scandinavian journal of gastroenterology · 2011
    Randomized trial67 participantsEnergy forAcetyl L-Carnitine
  15. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y · Experimental and therapeutic medicine · 2020
    Randomized trial239 participantsEnergy forAcetyl L-Carnitine
  16. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
    Kumar R; Nuñez NA; Joshi N; Joseph B; Verde A; Seshadri A; Cuellar Barboza AB; Prokop LJ; Medeiros GC; Singh B · Bipolar disorders · 2024
    Systematic reviewEnergy forAcetyl L-Carnitine
  17. Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
    Malaguarnera G; Pennisi M; Gagliano C; Vacante M; Malaguarnera M; Salomone S; Drago F; Bertino G; Caraci F; Nunnari G; Malaguarnera M · Hepatitis monthly · 2014
    Randomized trial62 participantsMental Focus Productivity Boost forAcetyl L-Carnitine
  18. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
    Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B · La Clinica terapeutica · 1992
    Non-randomized trial17 participantsMental Focus forAcetyl L-Carnitine
  19. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
    Arnold LE; Amato A; Bozzolo H; Hollway J; Cook A; Ramadan Y; Crowl L; Zhang D; Thompson S; Testa G; Kliewer V; Wigal T; McBurnett K; Manos M · Journal of child and adolescent psychopharmacology · 2008
    Randomized trial112 participantsMental Focus forAcetyl L-Carnitine
  20. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE · The Cochrane database of systematic reviews · 2019
    Meta-analysis398 participants5 studies pooledMental Focus forAcetyl L-Carnitine
  21. Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism.
    Krims-Davis K; Ozola M; Razzivina V; Gukalova B; Konrade I; Dambrova M; Liepinsh E · Molecular nutrition & food research · 2025
    Randomized trialMetabolism Boost forAcetyl L-Carnitine